Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADDAG trial of intraoperative dexamethasone and postoperative glucose in surgical patients with and without diabetes
ACTRN12614001145695Phase 4Completed
- Sponsor
- Royal Perth Hospital
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Royal Perth Hospital. Primary endpoint: Peak postoperative blood glucose concentrations. Started Mar 2015; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ACTRN12614001145695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001145695.